electroCore to Participate at Upcoming Investor Conferences
May 18 2022 - 8:00AM
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic
medicine company, today announced that electroCore’s Chief
Executive Officer, Dan Goldberger, will be presenting at the H.C.
Wainwright Global Investment Conference and LD Micro Invitational
Conference.
H.C. Wainwright Global Investment
ConferenceDate: Tuesday, May 24, 2022 Time: 7:00 AM
EDTWebcast: H.C. Wainwright WebcastLD Micro Invitational
ConferenceDate: Tuesday, June 7, 2022Time: 10:30 AM
PDTVirtual Viewers: LivestreamFollowing the conferences, a webcast
replay of the presentations will be available on the Investor
section of the company’s website, electroCore.
About electroCore, Inc.electroCore, Inc. is a
commercial stage bioelectronic medicine company dedicated to
improving patient outcomes through its non-invasive vagus nerve
stimulation therapy platform, initially focused on the treatment of
multiple conditions in neurology. The company's current indications
are the preventive treatment of cluster headache and migraine, the
acute treatment of migraine and episodic cluster headache, the
acute and preventive treatment of migraines in adolescents, and
paroxysmal hemicrania and hemicrania continua in adults.For more
information, visit
www.electrocore.com.Investors:Rich CockrellCG
Capital404-736-3838ecor@cg.capital
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From Aug 2024 to Sep 2024
electroCore (NASDAQ:ECOR)
Historical Stock Chart
From Sep 2023 to Sep 2024